Negocios · 8/6/20101 min de lectura
Issues in the Development of Medical Products for the Prophylaxis and/or Treatment of Acute Antibody Mediated Rejection in Kidney Transplant Recipients; Public Workshop
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing a public